Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.410
+0.050 (3.68%)
May 29, 2026, 4:00 PM EDT - Market closed

APUS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.981.6400.410.010.17
Short-Term Investments
1.52----
Cash & Short-Term Investments
2.483.6400.410.010.17
Cash Growth
890.46%105157.89%-99.16%6551.77%-96.40%-
Other Current Assets
10.6710.350.010.01-0
Total Current Assets
13.1513.980.010.420.010.17
Net Property, Plant & Equipment
0.230.24----
Other Long-Term Assets
127.84149.96----
Total Assets
141.22164.180.010.420.010.17
Accounts Payable
2.980.920.590.050.040.01
Accrued Expenses
0.610.530.110.07--
Short-Term Debt
1.430.510.33-0.28-
Current Portion of Long-Term Debt
7.947.09----
Current Portion of Leases
0.050.04----
Other Current Liabilities
1.571.62----
Total Current Liabilities
14.5810.711.020.120.320.01
Long-Term Debt
--0.350.270.40.4
Long-Term Leases
0.120.13----
Total Long-Term Liabilities
0.120.130.350.270.40.4
Total Liabilities
14.710.841.370.390.720.41
Common Stock
0.130.130.080.080.10.1
Additional Paid-in Capital
171.77163.542.952.951.411.22
Retained Earnings
-45.45-10.39-4.39-3-2.22-1.56
Total Common Shareholders' Equity
126.44153.27-1.360.03-0.71-0.24
Shareholders' Equity
126.52153.35-1.360.03-0.71-0.24
Total Liabilities & Equity
141.22164.180.010.420.010.17
Total Debt
9.557.770.670.270.680.4
Net Cash (Debt)
-7.07-4.14-0.670.14-0.68-0.23
Net Cash Per Share
-0.55-0.38-0.090.03-0.18-0.06
Book Value
126.44153.27-1.360.03-0.71-0.24
Book Value Per Share
9.9014.09-0.170.01-0.19-0.06
Tangible Book Value
126.44153.27-1.360.03-0.71-0.24
Tangible Book Value Per Share
9.9014.09-0.170.01-0.19-0.06
SEC Filings: 10-K · 10-Q